US Central Venous Catheters market

1
US Central Venous Catheters market
2
The various Drug Delivery Devices in North
America are Central Venous Catheters, Needle Free
Injections, Infusion Systems and Metered Dose
Inhaler Devices. Central venous catheter (CVC) is
long, thin hollow plastic tube that is inserted
into large vein of the neck or chest to
administer fluid, nutrients, medicine and blood
product or simply CVCs are used for drug
administration into a living body. CVCs are also
defined as central lines catheter or central
venous access devices (CVADs). It was estimated
that the use of CVCs will increase drastically
with the increasing number of aged population,
cancer patients, cardiovascular disorders and
population suffering from other chronic disease
in North America. Population depending on central
venous catheters are prone to bloodstream
infections and increasing the treatment cost. The
unfavourable events of central venous catheter
are they are hazardous to patient, and expensive
to treat which may indirectly hamper the growth
of the CVCs market.
3
According to the study North America Central
Venous Catheters Market Outlook to 2023, the
growing awareness in the American population
about the antimicrobial technology and the
increasing adoption of antimicrobial CVCs has a
positive impact on the growth of CVCs market.
CVCs are majorly used to prevention and control
of healthcare-associated infections and
complications in hospitals, outpatient settings,
and home healthcare settings. The central venous
catheters market is segmented into antimicrobial,
non-antimicrobial, and non-tunneled catheter
devices. The non-tunneled CVCs accounted for the
maximum shares of the central venous catheters
CVCs market. These are also known as subclavian,
percutaneous, and short-term catheters which are
used as an alternative to peripherally inserted
central catheters (PICC). The central venous
catheters market is again divided based on design
type such as single lumen, double lumen and multi
lumen. CVCs composition is divided based on
polyurethane, polyurethane/polycarbonate and
silicone.
4
There are many leading players in the central
venous catheters CVCs market and they focus on
providing a wide range of antimicrobial,
non-tunneled, and tunneled catheter devices.
Almost, all the manufacturers usually compete on
pricing and technology upgrade of CVCs. The
leading players in the CVCs market in North
America are Teleflex, B. Braun Melsungen AG, C.
R. Bard Inc, Vygon, Cook, Edwards Lifesciences
Corp and Smiths Medical. Few other players are
Amecath, AngioDynamics, BACTIGUARD, BD,
Biosensors International, Boston Scientific,
CONMED, Guangdong Baihe Medical Technology, Intra
special catheters, isomed, Kimal, lepumedical,
Medical Components, PRODIMED, SCW MEDICATH,
SILMAG, Smiths Medical, Terumo, TROGE MEDICAL,
TUOREN Medical, VOGT MEDICAL, and ZOLL Medical.
5
CVCs are majorly used in ambulatory surgical
centres (ASC), and hospitals which includes
multi-specialty hospitals, private hospitals, and
hospital groups. Majority of the hospitals
performing dialysis procedures for urological and
renal disorders experience an increased influx of
patients and a large number of catheterization is
required. The central venous catheters
manufacturing cost analysis includes cost
involved for raw materials, labor and
manufacturing expenses. This also includes
distribution, market concentration and
fluctuations in price trends. The introduction of
healthcare reforms and safety guidelines in North
America are the key factors that will have a
positive impact on CVCs market growth over the
coming years.
6
To know more, click on the link
below https//www.kenresearch.com/healthcare/medic
al-devices/north-america-central-venous-catheters-
market/135967-91.html   Related Reports BRIC
Central Venous Catheters Market Outlook to 2023
Asia-Pacific Central Venous Catheters Market
Outlook to 2023    Contact UsKen
ResearchAnkur Gupta, Head Marketing
CommunicationsAnkur_at_kenresearch.com91-901537824
9
7
(No Transcript)